First-Line Treatment for Typhoid Fever

Treatment Algorithm Based on Geographic Origin and Resistance Patterns

• The American College of Physicians recommends starting with azithromycin 500 mg daily for 7 days as empiric therapy for patients from South/Southeast Asia, due to high fluoroquinolone resistance rates 1, 2
• Azithromycin demonstrates superior outcomes with lower clinical failure rates (OR 0.48) and significantly reduced relapse risk (OR 0.09 compared to ceftriaxone) 1

Critical Treatment Duration

• The Infectious Diseases Society of America recommends continuing treatment for 14 days regardless of agent used to minimize relapse risk 2, 3, 4
• Relapse rates are as follows: azithromycin <3%, ceftriaxone <8%, fluoroquinolones <8% 2, 3, 4

Alternative Oral Agents (Second-Line)

• Cefixime can be used as an alternative oral agent, though treatment failure rates of 4-37.6% have been reported 2

Critical Pitfalls to Avoid

• The Centers for Disease Control and Prevention advises against using ciprofloxacin empirically for cases from South/Southeast Asia due to widespread resistance and poor clinical outcomes despite in vitro "susceptibility" 1, 5, 6
• Ciprofloxacin disc testing is unreliable; isolates must also be nalidixic acid-sensitive to be truly fluoroquinolone-susceptible 3

Monitoring for Treatment Response

• Expect fever clearance within 4-5 days of appropriate therapy, and consider alternative diagnoses or resistant organisms if no clinical response within 24-48 hours 1, 2
• Common azithromycin adverse effects include gastrointestinal symptoms (nausea, vomiting, abdominal pain, diarrhea) 1
• Obtain blood cultures before initiating therapy when possible, as sensitivity is 40-80% in the first week 3, 4